• Users Online: 295
  • Print this page
  • Email this page
Year : 2013  |  Volume : 4  |  Issue : 3  |  Page : 177-179

Hit hard and early: Can the march of psoriasis be halted?

Department of Dermatology, INHS Sanjivani, Naval Base, Kochi, Kerala, India

Correspondence Address:
Sridhar Jandhyala
INHS Sanjivani, Naval Base, Kochi - 682 004, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2229-5178.115510

Rights and Permissions

Psoriasis is increasingly considered a systemic disease with comorbidities. There is sufficient evidence that systemic inflammation lies at the heart of these developments. Considering the chronic nature of psoriasis and its comorbidities, timely manipulation of systemic inflammation could avert both mortality and morbidity. Data from retrospective studies suggest that aggressive treatment of psoriasis with traditional systemic agents and/or biologic drugs improves health outcomes. To maximize treatment outcomes, severe psoriasis needs to be managed as a systemic disease with likely comorbidities.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded426    
    Comments [Add]    
    Cited by others 1    

Recommend this journal